Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report. [electronic resource]
- Journal of neurology Sep 2018
- 2152-2153 p. digital
Publication Type: Case Reports; Letter
1432-1459
10.1007/s00415-018-8976-7 doi
Adult Alemtuzumab--therapeutic use Female Humans Immunologic Factors--therapeutic use Multiple Sclerosis, Relapsing-Remitting--blood Neutropenia--etiology